CareLit Fachartikel

NSAIDs repress BACE1 gene promoter activity by activation of PPARgamma

M Sastre, S Roßner, N Bogdanovic, E Rosen, I Dewachter, P Borghgraef, B Evert, L Dumitrescu-Ozimek, D Thal, G Landreth, J Walter, T Klockgether, F van Leuven, M.T Heneka · Aktuelle Neurologie · 2005 · Heft 10

Dokument
853909
CareLit-ID
Jahr
2005
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Neurologie
Autor:innen
M Sastre, S Roßner, N Bogdanovic, E Rosen, I Dewachter, P Borghgraef, B Evert, L Dumitrescu-Ozimek, D Thal, G Landreth, J Walter, T Klockgether, F van Leuven, M.T Heneka
Ausgabe
Heft 10 / 2005
Seiten
–
Erschienen: 2005-10-26 00:00:00
ISSN
0302-4350

Zusammenfassung

Epidemiological evidence suggests that non-steroidal anti-inflammatory drugs (NSAIDs) decrease the risk for Alzheimer's disease (AD). Certain NSAIDs can activate the peroxisome proliferator-activated receptor-gamma (PPARg), which is a nuclear transcriptional regulator. Here we show that PPARg depletion potentiates beta-secretase (BACE1) mRNA levels by increasing BACE1 gene promoter activity. Conversely, overexpression of PPARg as well as NSAIDs and PPARg activators, reduced BACE1 gene promoter activity. These results suggested that PPARg could be a repressor of BACE1. We then identified a PPARg responsive elemen…

Schlagworte

Aktuelle Neurologie